H LUNDBECK A S [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
03/16/2020	Enliven Therapeutics, Inc.	IMRA	Conversion	Series Seed Preferred Stock	499.1k	$0.00	$0		03/16/2020
03/16/2020	Enliven Therapeutics, Inc.	IMRA	Conversion	Common Stock	79.2k	$0.00	$0		03/16/2020
10/22/2019	ALDER BIOPHARMACEUTICALS INC	ALDR	Other (acquisition)	Class A-1 Convertible Preferred Stock	0	$0.00	$0	See Footnotes	10/22/2019
10/22/2019	ALDER BIOPHARMACEUTICALS INC	ALDR	Purchase	Common Stock, par value $0.0001	85.9M	$0.00	$0	See Footnotes	10/22/2019